Prenetics Global Ltd (PRE) - Total Liabilities
Based on the latest financial reports, Prenetics Global Ltd (PRE) has total liabilities worth $35.30 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Prenetics Global Ltd to see how much of total assets are deployed in long-term investments.
Prenetics Global Ltd - Total Liabilities Trend (2000–2024)
This chart illustrates how Prenetics Global Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Prenetics Global Ltd total assets.
Prenetics Global Ltd Competitors by Total Liabilities
The table below lists competitors of Prenetics Global Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Skyray Instrument Co
SHE:300165
|
China | CN¥2.02 Billion |
|
Regal Partners Ltd
AU:RPL
|
Australia | AU$177.61 Million |
|
Tufton Oceanic Assets Ltd
LSE:SHIP
|
UK | $9.36 Million |
|
Northeast Community Bancorp Inc
NASDAQ:NECB
|
USA | $1.75 Billion |
|
China Lilang Limited
F:5LX
|
Germany | €2.28 Billion |
|
Pharmaniaga Bhd
KLSE:7081
|
Malaysia | RM1.87 Billion |
|
Dingdong (Cayman) Limited ADR
NYSE:DDL
|
USA | $5.58 Billion |
|
Viva Wine Group AB
ST:VIVA
|
Sweden | Skr3.20 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Prenetics Global Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Prenetics Global Ltd balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Prenetics Global Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Prenetics Global Ltd (2000–2024)
The table below shows the annual total liabilities of Prenetics Global Ltd from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $42.23 Million | -4.05% |
| 2023-12-31 | $44.01 Million | -35.90% |
| 2022-12-31 | $68.67 Million | -87.50% |
| 2021-12-31 | $549.40 Million | +1047.55% |
| 2020-12-31 | $47.88 Million | +273.05% |
| 2019-12-31 | $12.83 Million | -99.91% |
| 2015-12-31 | $14.50 Billion | -4.37% |
| 2014-12-31 | $15.17 Billion | -6.80% |
| 2013-12-31 | $16.27 Billion | +1.40% |
| 2012-12-31 | $16.05 Billion | -2.08% |
| 2011-12-31 | $16.39 Billion | +1.43% |
| 2010-12-31 | $16.16 Billion | +0.44% |
| 2009-12-31 | $16.09 Billion | +33.17% |
| 2008-12-31 | $12.08 Billion | +3.11% |
| 2007-12-31 | $11.72 Billion | +4.95% |
| 2006-12-31 | $11.16 Billion | +4.80% |
| 2005-12-31 | $10.65 Billion | +16.29% |
| 2004-12-31 | $9.16 Billion | +10.24% |
| 2003-12-31 | $8.31 Billion | +24.74% |
| 2002-12-31 | $6.66 Billion | +22.95% |
| 2001-12-31 | $5.42 Billion | +35.25% |
| 2000-12-31 | $4.01 Billion | -- |
About Prenetics Global Ltd
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more